Washington, D.C. 20549





Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): February 12, 2020


Atomera Incorporated

(Exact name of registrant as specified in its charter)


Delaware 001-37850 30-0509586
(State or Other Jurisdiction (Commission File (I.R.S. Employer
of Incorporation) Number) Identification Number)


750 University Avenue, Suite 280

Los Gatos, California 95032

(Address of principal executive offices) (zip code)


(408) 442-5248

(Registrant’s telephone number, including area code)



(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:


Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock: Par value $0.001 ATOM Nasdaq Capital Market


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company x


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x








Item 2.02 Results of Operations and Financial Condition


On February 12, 2020, Atomera Incorporated issued a press release announcing its financial results for the three and twelve months ended December 31, 2019. The Company also intends to conduct an earnings call over which it will distribute an investor presentation. The text of the press release is attached hereto as Exhibit 99.1 and the investor presentation is attached hereto as Exhibit 99.2, both are incorporated by reference herein.


The information in this Current Report, including the exhibits attached hereto, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act regardless of any general incorporation language in such filing.


Item 9.01 Financial Statements and Exhibits.


(d) Exhibits:


99.1 Press release dated February 12, 2020 Atomera Incorporated
99.2 Investor presentation February 12, 2020 Atomera Incorporated






















Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.





  By: /s/ Francis Laurencio
    Francis Laurencio
    Chief Financial Officer



Date: February 12, 2020






















Exhibit 99.1





Atomera Provides Fourth Quarter and Fiscal 2019 Results


LOS GATOS, Calif. Feb. 12, 2020 Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the semiconductor industry, today provided a corporate update and announced financial results for the fourth quarter and fiscal year ended December 31, 2019.


Company Highlights


· Record amount of customer activity as measured by wafer shipments and phase 3 engagements
· Strong technical results in each of Atomera’s focus areas
· Strong cash position


Management Commentary


“Atomera has exited 2019 with very strong momentum, with more customer activity than at any time in our history,” said Scott Bibaud, President and CEO. “Our recent technology and customer advances give us confidence to increase investment in our business to accelerate our progress toward additional licenses and revenue growth.”


Financial Results


During the fourth quarter of 2019, revenue was $138,000, compared with $150,000 in the fourth quarter of 2018. The Company incurred a net loss of $(3.0) million, or ($0.18) per basic and diluted share in the fourth quarter of 2019, compared to a net loss of $(3.2) million, or ($0.22) per basic and diluted share, for the fourth quarter of 2018. Adjusted EBITDA (a non-GAAP financial measure) in the fourth quarter of 2019 was a loss of $(2.4) million compared to an adjusted EBITDA loss of $(2.7) million in the fourth quarter of 2018.


For fiscal year 2019, revenue was $533,000, compared with $246,000 in fiscal 2018. Net loss was $(13.3) million, or ($0.84) per basic and diluted share for fiscal 2019, compared to $(12.9) million, or ($1.02) per basic and diluted share in fiscal 2018. Adjusted EBITDA for fiscal 2019 was a loss of $(10.7) million compared to an adjusted EBITDA loss of $(10.7) million in fiscal 2018.


The Company had $14.9 million in cash and cash equivalents as of December 31, 2019, compared to $18.9 million as of December 31, 2018.


The total number of shares outstanding was 17.1 million as of December 31, 2019.







Fourth Quarter and Fiscal Year 2019 Results Conference Call and Webcast


Atomera will host a conference call today to discuss its financial results and recent progress.

Date: Wednesday, Feb. 12, 2020

Time: 2:00 p.m. PT (5:00 p.m. ET)

Phone: (844) 263-8318 (domestic); +1 (213) 358-0960 (international)

Replay: Available until Feb. 19, 2020; (855) 859-2056 (domestic); +1(404) 537-3406 (international); passcode 8660938

Webcast: Accessible at www.atomera.com


Note about NonGAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a nonGAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stockbased compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarlytitled measures used by other companies. We believe that this nonGAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.


About Atomera Incorporated

Atomera Incorporated has developed Mears Silicon Technology™ ("MST®"), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nanoscaling technologies already in the semiconductor industry roadmap.


Safe Harbor

This press release contains forwardlooking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forwardlooking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues and we have not yet commenced principal revenue producing operations or entered into a definitive royalty-based manufacturing and distribution license agreement with regard to our MST technology, thus subjecting us to all of the risks inherent in an early-stage enterprise; (2) risks related to our ability to advance the licensing arrangements with our initial integration licensees, Asahi Kasei Microdevices and STM Microelectronics, to royalty-based manufacturing and distribution licenses or our ability to add other licensees; (3) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (4) our ability to protect our proprietary technology, trade secrets and knowhow and (5) those other risks disclosed in the section "Risk Factors" included in our Prospectus Supplement filed with the SEC on May 30, 2019. We caution readers not to place undue reliance on any forwardlooking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.


-- Financial Tables Follow --








Atomera Incorporated

Balance Sheets

(in thousands, except per share data)


    December 31,     December 31,  
    2019     2018  
Current assets:                
Cash and cash equivalents   $ 14,871     $ 18,933  
Accounts receivable           185  
Prepaid expenses and other current assets     132       170  
Total current assets     15,003       19,288  
Property and equipment, net     63       56  
Operating lease right-of-use asset     161        
Security deposit     13       13  
Total assets   $ 15,240     $ 19,357  
Current liabilities:                
Accounts payable   $ 315     $ 348  
Accrued expenses     145       224  
Accrued payroll related expenses     819       984  
Current operating lease liability     152        
Deferred revenue     37       55  
Total liabilities     1,468       1,611  
Commitments and contingencies                
Stockholders’ equity:                
Preferred stock, $0.001 par value, authorized 2,500 shares; none issued and outstanding at December 31, 2019 and December 31, 2018            
Common stock, $0.001 par value, authorized 47,500 shares; 17,117 and 15,034 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively.     17       15  
Additional paid-in capital     149,017       139,693  
Accumulated deficit     (135,262 )     (121,962 )
Total stockholders’ equity     13,772       17,746  
Total liabilities and stockholders’ equity   $ 15,240     $ 19,357  








Atomera Incorporated

Condensed Statements of Operations

(in thousands, except per share data)



Three Months Ended

December 31,


Year Ended

December 31,

    2019     2018     2019     2018  
    (Unaudited)     (Unaudited)     (Unaudited)        
Revenue   $ 138     $ 150     $ 533     $ 246  
Cost of revenue     (29 )     (35 )     (253 )     (148 )
Gross margin     109       115       280       98  
Operating expenses                                
Research and development     1,818       1,968       7,748       7,318  
General and administrative     1,155       1,175       5,203       4,956  
Selling and marketing     242       262       954       957  
Total operating expenses     3,215       3,405       13,905       13,231  
Loss from operations     (3,106 )     (3,290 )     (13,625 )     (13,133 )
Other income                                
Interest income     60       91       325       236  
Total other income     60       91       325       236  
Net loss   $ (3,046 )   $ (3,199 )   $ (13,300 )   $ (12,897 )
Net loss per common share, basic and diluted   $ (0.18 )   $ (0.22 )   $ (0.84 )   $ (1.02 )
Weighted average number of common shares outstanding, basic and diluted     16,606       14,364       15,852       12,655  














Atomera Incorporated

Reconciliation to Non- GAAP EBITDA




Three Months Ended

December 31,


Year Ended

December 31,

    2019     2018     2019     2018  
Net loss (GAAP)   $ (3,046 )   $ (3,199 )   $ (13,300 )   $ (12,897 )
Add (subtract) the following items:                                
Interest income     (60 )     (91 )     (325 )     (236 )
Depreciation and amortization     11       9       44       33  
Stock-based compensation     649       629       2,929       2,425  
Adjusted EBITDA (non-GAAP)   $ (2,446 )   $ (2,652 )   $ (10,652 )   $ (10,675 )




Investor Contact:

Bishop IR

Mike Bishop

(415) 894-9633


















Exhibit 99.2


Q4 2019 Conference Call February 12, 2020 1


2 Safe Harbor This presentation contains forward - looking statements concerning Atomera Incorporated (““Atomera,” the “Company,” “we,” “us,” and “our”). The words “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “would,” “project,” “plan,” “expect” and similar expressions that convey uncertainty of future events or outcomes are intended to identify forward - looking statements. These forward - looking statements are subject to a number of risks, uncertainties and assumptions, including those disclosed in the section "Risk Factors" included in our Prospectus Supplement filed with the SEC on May 30, 2019. In light of these risks, uncertainties and assumptions, the forward - looking events and circumstances discussed in this presentation may not occur and actual results could differ materially and adversely from those anticipated or implied in our forward - looking statements. You should not rely upon forward - looking statements as predictions of future events. Although we believe that the expectations reflected in our forward - looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances described in the forward - looking statements will be achieved or occur. This presentation contains only basic information concerning Atomera. The Company’s filings with the Securities Exchange Commission, including the Prospectus Supplement , include more information about factors that could affect the Company’s operating and financial results. We assume no obligation to update information contained in this presentation. Although this presentation may remain available on the Company's website or elsewhere, its continued availability does not indicate that we are reaffirming or confirming any of the information contained herein.


Mears Silicon Technology (MST®) Quantum Engineered Materials 3 Company Overview Strong, Growing and Defensible Patent Portfolio High Leverage IP Licensing Business Model Top Tier Management Team Transistor enhancement technology for the $450B semiconductor market 3


4 Customer engagements • 19 customers, 25 engagements • Working with 50% of the world’s top semiconductor makers* 0 3 6 9 12 15 18 21 24 27 IPO 3Q 16 4Q 16 1Q 17 2Q 17 3Q 17 4Q 17 1Q 18 2Q 18 3Q 18 4Q 18 1Q 19 2Q 19 3Q 19 4Q 19 Number of Customer Engagements Phase 1 Phase 2 Phase 3 * 10 of the top 20 (IC Insights, McClean Report 2019)


5 Customer engagement model v Customer Wafer Manufacturing Atomera MST ® Deposition Customer MST ® Deposition Phase 1 . Planning 2 . Setup 3 . Integration 4 . Installation 5 . Qualification 6 . Production Royalties Engineering Service Fees • MST deposition on customer wafers • Integration consulting License Fees • Integration licenses • Manufacturing licenses • Distribution licenses


6 MST - SP progress 0.0 0.5 1.0 1.5 2.0 2.5 3.0 Feb-19 May-19 Aug-19 Dec-19 Mar-20 Jun-20 Sep-20 MST SP Progress Control MST SP Industry Top Runner R SP (m Ω - mm 2 ) May 2019 Result Atomera R&D fab Current Result Atomera R&D fab Industry top - runners Projected Current Result Advanced fab


7 MST matching performance  Transistor mismatch is an industry problem  Certain circuit designs benefit from mismatch reduction  A - D convertors  SRAM  Flash  DRAM sense amplifiers  MST can reduce mismatch by more than 50%  Details available at Atomera’s website  blog.atomera.com 0 5 10 15 20 25 30 35 0 1 2 3 4 σ Δ V t h [ m V ] 1/(WL)^0.5 [1/μm] Si control MST process 1.8VNMOS data Smaller devices better matching


8 Financial review Q4 '18 Q1 '19 Q2 '19 Q3 '19 Q4 '19 FY 2019 GAAP Results Revenue $0.15M $0.07M $0.07M $0.25M $0.14M $0.53M Gross Profit $0.12M $0.07M $0.05M $0.05M $0.11M $0.28M Operating Expense R&D $2.0 $2.1 $2.1 $1.7 $1.8 $7.7 G&A $1.2 $1.3 $1.5 $1.2 $1.2 $5.2 S&M $0.3 $0.2 $0.2 $0.2 $0.2 $1.0 Total Operating Expense ($3.4M) $3.7M $3.8M $3.2M $3.2M $13.9M Net Loss ($3.2M) ($3.5M) ($3.6M) ($3.1M) ($3.0M) ($13.3M) Loss Per Share ($0.22) ($0.24) ($0.24) ($0.19) ($0.18) ($0.84) Reconciliation between GAAP & Non-GAAP Net Loss (GAAP) ($3.2M) ($3.5M) ($3.6M) ($3.1M) ($3.0M) ($13.3M) Stock-Based Compensation $0.6M $0.7M $0.8M $0.8M $0.6M $2.9M Other income (expense) ($0.1M) ($0.1M) ($0.1M) ($0.1M) ($0.0M) ($0.3M) Adjusted EBITDA (Non-GAAP)* ($2.6M) ($2.9M) ($2.9M) ($2.4M) ($2.4M) ($10.7M) *Adjusted EBITDA is a non-GAAP financial measure. A full reconciliation of GAAP and non-GAAP results is contained in our Q4 press release. Some totals reflect rounding. Cash $14.9M Debt - Shares Outstanding 17.1M Balance Sheet 12/31/19


Thank You 9